Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -5.45
- Piotroski Score 2.00
- Grade Neutral
- Symbol (ONCR)
- Company Oncorus, Inc.
- Price $0.12
- Changes Percentage (0%)
- Change $0.12
- Day Low $0.12
- Day High $0.12
- Year High $0.12
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers. It is also developing ONCR-GBM, a preclinical stage oHSV program for treating brain cancer through intratumoral injection; and synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. The company has a clinical trial collaboration and supply agreement with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 combined with Merck's cancer immunotherapy KEYTRUDA in its Phase 1 clinical trial in patients with solid tumors. Oncorus, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
- Last Earnings N/A
- Ex-Dividend for 5/16 Dividend 12/26/2023
- Dividend Payable N/A
- Today N/A
- Next Earnings (Estimated) 03/22/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$3.48
- Trailing P/E Ratio -0.036206896551724
- Forward P/E Ratio -0.036206896551724
- P/E Growth -0.036206896551724
- Net Income $-78,307,000
Income Statement
Quarterly
Annual
Latest News of ONCR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Rescue dog who slept on concrete and "flinch" at humans transformed by love
Juniper, a retired racing greyhound rescued by Vera Johansson, has transformed from a fearful, neglected dog to a loving companion. Johansson hopes Juniper's journey will inspire others to adopt and r...
By Newsweek | 1 week ago -
Father and 9-Year-Old Son Killed After Watercraft Slams into Concrete Seawall in Florida
Brenton Blanchet is a writer-reporter at PEOPLE since 2022, with work featured in Billboard, Pigeons & Planes, and Complex....
By PEOPLE.com | 4 weeks ago -
Miami father, 9-year-old son killed after Waverunner slams into concrete seawall in Keys
A 47-year-old man and his son tragically died in a watercraft crash in Florida. The man and his son were on a 2018 Yamaha watercraft that collided with a seawall at high speed....
By USA Today | 4 weeks ago
